Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Save the date: Roche Analyst Event at ASCO 2018 Mittwoch, 14. März 2018 - 10:03

Investor Update

DC7C4498-0016-7141-8FDE-9EDDD4751568.jpg
 

Save the date: Roche Analyst Event at ASCO 2018

divider.png

Monday, 4 June 2018

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Date/Time
Monday, 4 June 2018 @ 5:30pm Central Daylight Time CDT (Chicago)
The briefing will be followed by a buffet reception.

Venue
Marriott Downtown Chicago
540 North Michigan Avenue
60611 Chicago
map

An invitation with the detailed programme and registration form will soon follow.


Best regards,

Karl Mahler
Head of Investor Relations


Sabine Borngräber
Investor Relations Officer

 
 

Roche Investor Relations

Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com                 

Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com 

Dr. Birgit Masjost 
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com

Dr. Sabine Borngräber 
Phone: +41 61 68-88027 
e-mail: sabine.borngraeber@roche.com 

Dr. Susann Manchado 
Phone: +41 61-68-75619 
e-mail: susann.manchado@roche.com


Investor Relations North America

Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com           

Loren Kalm 
Phone: +1 650 225 3217 
e-mail: kalm.loren@gene.com